Direct Oral Anticoagulants versus Vitamin K Antagonists in Cerebral Venous Thrombosis: A Systematic Review and Meta-analysis (P7-4.010) | Synapse
June 13, 2026
Direct Oral Anticoagulants versus Vitamin K Antagonists in Cerebral Venous Thrombosis: A Systematic Review and Meta-analysis (P7-4.010)
Key Points
This meta-analysis compares the effectiveness and safety of direct oral anticoagulants and vitamin K antagonists in treating cerebral venous thrombosis.
Conducted a systematic review and meta-analysis of available studies on DOACs and VKAs for CVT.
Analyzed effectiveness and safety outcomes from included studies.
Evaluated multiple databases for relevant literature.
Found that DOACs had significant effectiveness in treating CVT compared to VKAs.
Safety profiles of DOACs were either superior or comparable to VKAs in the analyzed studies.
Abstract
This meta-analysis aims to compare the effectiveness and safety of direct oral anticoagulants (DOACs) with those of vitamin K antagonists (VKAs) in treating cerebral venous thrombosis (CVT).